Close Menu

NEW YORK – The Foundation for Innovative New Diagnostics (FIND) on Wednesday issued an expression of interest (EOI) to developers of tests for the novel coronanvirus, SARS-CoV-2, who are interested in getting their assays evaluated using a standardized, independent protocol.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.